#cdsco
Before You Sell Medical Devices in India: Get CDSCO Registration

Selling medical devices without CDSCO clearance risks heavy fines and immediate stock seizures. LegalRaasta simplifies Medical Device Registration for manufacturers and importers across India.
Medical Device Registration in India — CDSCO License (2026)
Register your medical device with CDSCO online in India. 2026 guide on Class A–D classification, SUGAM portal, DMF/PMF documents, fees, timelines & eligibility.
www.legalraasta.com
September 29, 2026 at 9:59 AM
youtu.be/V9s2DIi7af0?...

Drug alert: 220 drug samples declared as NSQ in August 2026.
29 from CDSCO and 191 from States.

#nsqdrugs #nsqmedicine #DrugAlert #nsqlist #FDAAlert
Drug alert: 220 drug samples declared as NSQ in August 2026.29 from CDSCO and 191 from States.
YouTube video by The Health Master
youtu.be
September 26, 2026 at 9:46 AM
youtube.com/shorts/8HVul...

Drug alert: 220 drug samples declared as NSQ in August 2026.
29 from CDSCO and 191 from States.

#nsqdrugs #nsqmedicine #DrugAlert #nsqlist #FDAAlert
Drug alert: 220 drug samples declared as NSQ in August 2026.29 from CDSCO and 191 from States.
YouTube video by The Health Master
youtube.com
September 26, 2026 at 6:26 AM
India shifts antibiotic manufacturing approvals to central control, removing state regulators in attempt to fight #AMR. CDSCO will regulate licensing to reduce misuse and prevent part of the 600,000 annual deaths. #PublicHealth
India to centralize antibiotic manufacturing approvals, stripping state regulators of this power to combat #AMR. CDSCO will oversee licensing to curb misuse contributing to 600,000 deaths annually. #AMR #globalhealth #infectiousdisease

www.livemint.com/politics/pol...
www.livemint.com
February 17, 2025 at 5:26 PM
ICMR and CDSCO have created a framework to validate rapid tests for pathogen identification and antimicrobial resistance, aiming to improve diagnoses and reduce antibiotic misuse in India.
January 19, 2025 at 5:17 PM
India to centralize antibiotic manufacturing approvals, stripping state regulators of this power to combat #AMR. CDSCO will oversee licensing to curb misuse contributing to 600,000 deaths annually. #AMR #globalhealth #infectiousdisease

www.livemint.com/politics/pol...
www.livemint.com
February 17, 2025 at 5:23 PM
India's drug regulator, CDSCO, has directed all states to strengthen oversight of veterinary antibiotic use by forming a joint working group to collect and monitor data on the production, sale, and import of these drugs. This move aims to combat #AMR.
#OneHealth
www.news18.com/india/govt-c...
Govt Cracks Down On Animal Antibiotics, Tightens Oversight On Drug Sales & Imports
Antimicrobial-resistant bacteria of animal origin can be transmitted to humans through the environment and food products, possibly leading to a public health crisis
www.news18.com
June 9, 2025 at 6:36 AM
CDSCO Guidelines for Sampling of Drugs, Cosmetics and Medical Devices

thehealthmaster.com/2026/05/28/c...
CDSCO Guidelines for Sampling of Drugs, Cosmetics and Medical Devices
Guidelines for Sampling The Central Drugs Standard Control Organisation (CDSCO) has issued uniform guidelines for sampling of Drugs, Cosmetics and Medical Devi
thehealthmaster.com
May 28, 2026 at 3:12 PM
CDSCO Registration for Dental Consumables & Devices - A complete guide for clinics & importers in India. medicaldeviceregistration.com/blog/cdsco-r... #CDSCO #MedicalDevice #DentalDevices
CDSCO Registration for Dental Consumables & Devices
Navigate CDSCO registration for dental consumables and devices in India. Learn classification, process, documents, and compliance for importers and manufacturers.
medicaldeviceregistration.com
March 11, 2026 at 11:05 AM
16 Banned FDC Drugs in India: Check Complete List

The Indian government has banned 16 Fixed-Dose Combination (FDC) drugs. Check the complete CDSCO list, reasons for the ban, and safe patient guidelines.

www.mrmed.in/health-libra...
#FDCDrugs #HealthRisks #Mrmed
16 FDC Drugs Banned by Government: Full List & Patient Guide
Check the complete list of 16 banned fixed-dose combination (FDC) drugs in India, why they were banned, health risks, and what patients should do.
www.mrmed.in
September 30, 2026 at 6:13 AM
We're cruelty-free. 🐰 We're vegan. 🌱 We're CDSCO certified. ✅ We have VerifEye anti-counterfeiting. 🔐 Luxury without compromise. That's Yuri Woori. #YuriWoori #CleanBeauty
#VeganSkincare #KoreanSkincare
March 22, 2026 at 12:01 PM
#CDSCO flags 60 drugs as substandard, including eye drops, IV fluids, and emergency drugs in April 2025 alert.

www.medboundtimes.com/pharmacy/cds...
CDSCO Flags 60 Substandard Drugs, Including Critical Injectables
CDSCO Flags 60 Substandard Drugs, Including Critical Injectables
www.medboundtimes.com
May 27, 2025 at 10:55 AM
CDSCO Flags 205 Substandard Drugs in November 2025

New Delhi | December 19,2025 | SKY LINK TIMES CDSCO Flags 205 Substandard Drugs: India’s apex drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has flagged 205 drug samples as Not of Standard Quality (NSQ) in its monthly…
CDSCO Flags 205 Substandard Drugs in November 2025
New Delhi | December 19,2025 | SKY LINK TIMES CDSCO Flags 205 Substandard Drugs: India’s apex drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has flagged 205 drug samples as Not of Standard Quality (NSQ) in its monthly drug safety alert for November 2025, raising fresh concerns over medicine quality and regulatory compliance across the country. CDSCO Flags 205 Substandard Drugs in November 2025…
skylinktimes.in
December 19, 2025 at 11:33 AM
India is betting on biopharma to move beyond generics, but gaps in R&D, raw materials, regulation, talent and cold-chain logistics could determine how far the industry goes.

#Biologics #Roche #CentralGovernmentHealthScheme #NIPERs #CDSCO #ASEAN #SHAKTI
Is India ready for the biopharma revolution?
India is betting on biopharma to move beyond generics, but gaps in R&D, raw materials, regulation, talent and cold-chain logistics could determine how far the industry goes.
www.itln.in
September 28, 2026 at 7:48 AM
Indian gormint is slowly becoming pro-lifer...

Over-the-counter sale ban likely on morning-after pill... expert committee all set to recommend that the Drugs and Cosmetic Rules of 1945 are suitably amended to make these drugs prescription-only drugs.
Over-the-counter sale ban likely on morning-after pill
CHENNAI: The Central Drugs Standard Control Organisation (CDSCO) is likely to recommend a ban on the over-the-counter (OTC) sale of all hormonal contraceptive d
www.newindianexpress.com
October 4, 2024 at 1:41 PM
インドのCDSCOが、アストラゼネカのEnhertu(トラスツズマブ デルクステカン)とペルツズマブ併用療法を、切除不能または転移性HER2陽性乳がん成人患者の新たな一次治療として承認しました。
www.ipharmacenter.com/post/cdsco-a...
#Enhertu #アストラゼネカ #HER2 #乳がん #CDSCO #インド #ニュース #製薬 #医薬品 #医療
CDSCO Approves AstraZeneca's Enhertu as New First-Line Combination for HER2-Positive Breast Cancer in India
AstraZeneca Pharma India has secured regulatory clearance from the Central Drugs Standard Control Organisation (CDSCO) to introduce a new first-line therapeutic option for adults facing unresectable o...
www.ipharmacenter.com
June 26, 2026 at 5:06 AM
CDSCO Registration and Healthcare Business Compliance in India.

Planning to start or expand a healthcare business? Know why regulatory approvals matter for investors and businesses.

expert-business-consultants.blogspot.com/2026/09/why-...

#CDSCORegistrationOnline #CDSCORegistration #Corpbiz
Why Investors Prefer CDSCO-Compliant Healthcare Businesses
Discover why investors value CDSCO-compliant healthcare businesses and how medical device and cosmetic compliance can support business growth.
expert-business-consultants.blogspot.com
September 22, 2026 at 8:23 AM
दर्द निवारक दवाओं और एंटीबायोटिक के अनियंत्रित इस्तेमाल पर CDSCO की चेतावनी, किडनी की बीमारी के जोखिम को लेकर चिंता

23 सितंबर 2026 (भारत बाणी ब्यूरो)। भारत के शीर्ष औषधि नियामक केंद्रीय औषधि मानक नियंत्रण संगठन (CDSCO) ने दर्द निवारक दवाओं और एंटीबायोटिक के अनियंत्रित, बार-बार या लंबे समय तक…
दर्द निवारक दवाओं और एंटीबायोटिक के अनियंत्रित इस्तेमाल पर CDSCO की चेतावनी, किडनी की बीमारी के जोखिम को लेकर चिंता
23 सितंबर 2026 (भारत बाणी ब्यूरो)। भारत के शीर्ष औषधि नियामक केंद्रीय औषधि मानक नियंत्रण संगठन (CDSCO) ने दर्द निवारक दवाओं और एंटीबायोटिक के अनियंत्रित, बार-बार या लंबे समय तक इस्तेमाल के खिलाफ चेतावनी जारी की है। नियामक ने अनुचित दवा सेवन से होने वाली किडनी संबंधी जटिलताओं, क्रॉनिक किडनी डिजीज (CKD), प्रतिकूल दवा प्रतिक्रियाओं और एंटीमाइक्रोबियल रेजिस्टेंस (AMR) के जोखिम पर जोर दिया है।
bharatbaani.com
September 23, 2026 at 9:29 AM